Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Efficacy Extension Study of ONO-4641 (MSC2430913A) in Patients With Relapsing-Remitting Multiple Sclerosis

NCT01226745 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.

NCT NCT01226745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01226745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Efficacy Extension Study of ONO-4641 (MSC2430913A) in Patients With Relapsing-Remitting Multiple Sclerosis
Lead sponsor
EMD Serono
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2010
Completion date
January 31, 2015
Enrollment
340 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis